Pharmaron Health (02617.HK) is included in the Hang Seng Index series of constituent stocks.

Zhixin Finance APP News, Nova Wellness-B (02617.HK) announced that, according to the quarterly review results of the Hang Seng Index Series published by Hang Seng Index Company Limited on August 22, 2025, the company has been selected and will be included in the following Hang Seng Index Series constituent stocks, effective from September 8, 2025.